Drug factory · FDA FEI 2182207
Medtronic Neuromodulation
Minneapolis, Minnesota, United States
Matched to FDA's records by company name, because this plant's registration on the label has expired.
Problems found, fixed voluntarily at FDA's last inspection, May 9, 2012.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2010: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Baclofen | Makes it | Medtronic Neuromodulation | 58281-560, 58281-561, 58281-562 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| May 9, 2012 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 20, 2010 | No problems found | Postmarket Surv. and Epidemiology | — |
| Jul 20, 2010 | No problems found | Drug Quality Assurance | — |